Boulos Haraoui - Osteoarthritis Research Unit, University of Montreal Hospital Centre (CHUM)

基本信息

浏览量：27

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 124 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

AB0630 IMPACT OF JOINT INVOLVEMENT ON CHANGES IN PATIENT-REPORTED OUTCOMES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ABATACEPT

Pope J.,Sampalis J.,Haraoui B.,Rampakakis E., Allum F., Trepanier M.O.,Bessette L.

Annals of the Rheumatic Diseases (2024): 1600-1601

引用0浏览0引用

AB0634 PREDICTORS OF CDAI TRAJECTORIES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ABATACEPT: A REAL-WORLD STUDY

Bessette L.,Sampalis J.,Haraoui B.,Rampakakis E., Keating D., Trepanier M.O.,Pope J.

Annals of the Rheumatic Diseases (2024): 1602-1603

引用0浏览0引用

POS0640 REAL-WORLD EFFECTIVENESS AND SAFETY OF GP2015 IN PATIENTS WITH RHEUMATIC DISEASES: FINAL RESULTS OF THE COMPACT STUDY

M. Schmalzing,H. Kellner,A. Askari,J. De Toro Santos,J. C. Vazquez Perez-Coleman,R. Foti,S. Jeka,B. Haraoui,Y. Allanore, M. Rahman, F. Furlan,S. Hachaichi,T. Sheeran

Annals of the Rheumatic Diseases（2022）

引用1浏览0引用

REAL-WORLD EFFECTIVENESS AND SAFETY OF GP2015 IN PATIENTS WITH RHEUMATIC DISEASES: FINAL RESULTS OF THE COMPACT STUDY

M. Schmalzing,H. Kellner,A. Askari,J. De Toro Santos, J. C. Vazquez Perez-Coleman,R. Foti,S. Jeka,B. Haraoui,Y. Allanore, M. Rahman, F. Furlan,S. Hachaichi,T. Sheeran

ANNALS OF THE RHEUMATIC DISEASES（2022）

引用1浏览0引用

Clinical Responses to Upadacitinib or Abatacept in Patients with Rheumatoid Arthritis by Type of Prior Biologic Disease-Modifying Antirheumatic Drug: Data from the Phase 3 SELECT-CHOICE Study

A. Rubbert-Roth,R. Xavier,B. Haraoui,H. S. B. Baraf,M. Rischmueller,N. Martin,Y. Song,J. Suboticki,J. Cush

Annals of the rheumatic diseases（2021）

引用1浏览0引用

POS0232 CLINICAL EFFECTIVENESS OF ADALIMUMAB VERSUS NON-BIOLOGIC THERAPY IN THE MANAGEMENT OF EXTRA-ARTICULAR MANIFESTATIONS IN ANKYLOSING SPONDYLITIS PATIENTS OVER 24 MONTHS – RESULTS OF THE COMPLETE-AS CANADIAN OBSERVATIONAL STUDY

L. Bessette,B. Haraoui,B. Florica,M. C. Laliberte,M. Khraishi

ANNALS OF THE RHEUMATIC DISEASES（2021）

引用3浏览0引用

POS0086 ANALYSIS OF DISEASE ACTIVITY MEASURES IN THE CONTEXT OF A METHOTREXATE WITHDRAWAL STUDY AMONG PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOFACITINIB 11 MG ONCE DAILY + METHOTREXATE: POST HOC ANALYSIS OF DATA FROM ORAL SHIFT

R. Fleischmann,B. Haraoui,M. H. Buch,D. Gold, G. Sawyerr,H. Shi,A. Diehl,K. Lee

Annals of the Rheumatic Diseases（2021）

引用1浏览0引用

AB0337 TOFACITINIB MONOTHERAPY OR COMBINED WITH METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS SHOW SIMILAR RETENTION OVER FOUR YEARS. REPORT FROM RHUMADATA ®

D. Choquette,L. Bessette, L. Choquette Sauvageau, I. Ferdinand,B. Haraoui,F. Massicotte,J. P. Pelletier,J. P. Raynauld,M. A. Remillard,D. Sauvageau,E. Villeneuve,L. Coupal

ANNALS OF THE RHEUMATIC DISEASES（2020）

引用1浏览0引用

EFFICACY AND SAFETY OF UPADACITINIB VERSUS ABATACEPT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-CHOICE): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL

A. Rubbert-Roth,J. Enejosa,A. Pangan,R. Xavier,B. Haraoui,M. Rischmueller,N. Khan, Y. Zhang,N. Martin,M. C. Genovese

ANNALS OF THE RHEUMATIC DISEASES（2020）

引用5浏览0引用

Methotrexate Withdrawal in Patients with Rheumatoid Arthritis Who Achieve Low Disease Activity with Tofacitinib Modified-Release 11 Mg Once Daily Plus Methotrexate (ORAL Shift): a Randomised, Phase 3b/4, Non-Inferiority Trial (vol 1, Pg E23, 2019)

S. B. Cohen,J. Pope,B. Haraoui

LANCET RHEUMATOLOGY（2019）

引用32浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn